HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$1.95
Day range
$1.97 - $2.10
Year range
$0.61 - $3.65
Market cap
380.47M USD
Avg Volume
986.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 58.48M | -7.06% |
Net income | -59.45M | -1.07% |
Net profit margin | — | — |
Earnings per share | -0.35 | 5.41% |
EBITDA | -58.47M | 6.84% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.53M | -40.66% |
Total assets | 191.05M | -39.73% |
Total liabilities | 87.18M | 191.48% |
Total equity | 103.87M | — |
Shares outstanding | 182.04M | — |
Price to book | 3.25 | — |
Return on assets | -79.27% | — |
Return on capital | -93.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -59.45M | -1.07% |
Cash from operations | -47.96M | 4.74% |
Cash from investing | 42.65M | 143.16% |
Cash from financing | 58.77M | 277.37% |
Net change in cash | 53.46M | 140.02% |
Free cash flow | -54.93M | -86.78% |
About
Founded
2019
Headquarters
Website
Employees
96
